Mounjaro™ (tirzepatide) injection

2.5 mg/5 mg/7.5 mg/10 mg/12.5 mg/15 mg

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

Tirzepatide: Use in Patients with Pancreatitis

Tirzepatide has not been studied in patients with a history of pancreatitis.


Detailed Information

There is no information on the use of tirzepatide in people with a history of pancreatitis because patients were excluded from tirzepatide clinical trials if they had a history of chronic or acute pancreatitis any time prior to study entry.

Date of Last Review: February 05, 2021

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon – Friday, 9am-7pm (EST), excluding holidays

Or you can

Chat with us

Chat with us

Submit a Request

Visit Us @LillyMedical